Home › Peanut Hypersensitivity › Texas
Peanut Hypersensitivity clinical trials in Texas
4 studies for Peanut Hypersensitivity are looking for participants at sites in Texas.
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Western Sky Medical Research, El Paso
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- University of Texas Southwestern Medical Center: Division of Allergy and Immunology, Dallas
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Children's Health, Dallas
- Texas Children's Hospital/Baylor College of Medicine, Houston
RecruitingPhase 1Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Dell Children's Medical Group, Austin
- Texas Children's Hospital, Houston
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.